Recurrence of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Following Liver Transplantation for NASH Cirrhosis

被引：0
|
作者：
Matsuoka, Lea [1 ]
Slaughter, James [1 ]
Campbell, Kathyrn [1 ]
Kerr, Ashlie [1 ]
Hamel, Stephanie [1 ]
Garza, Carissa [1 ]
Chotai, Pranit [1 ]
Alexopoulos, Sophoclis [1 ]
Scanga, Andrew [1 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2021年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
OA-6
引用
收藏
页码：15 / 15
页数：1
相关论文
共 50 条
  • [1] Non-alcoholic fatty liver disease (NAFLD). Non-alcoholic steatohepatitis - NASH
    Keller, KM
    [J]. MONATSSCHRIFT KINDERHEILKUNDE, 2004, 152 (08) : 864 - 869
  • [2] Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment
    Bugianesi, E
    Marzocchi, R
    Villanova, N
    Marchesini, G
    [J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 (06) : 1105 - 1116
  • [3] Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV
    Jürgen Kurt Rockstroh
    [J]. Current HIV/AIDS Reports, 2017, 14 : 47 - 53
  • [4] Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV
    Rockstroh, Juergen Kurt
    [J]. CURRENT HIV/AIDS REPORTS, 2017, 14 (02) : 47 - 53
  • [5] Non-alcoholic fatty liver disease (NAFLD) recurrence after liver transplant (OLT) for non-alcoholic steatohepatitis(NASH)
    Kawamura, Norio
    Nazzal, Mustafa
    El-Gazzaz, Galal
    Spaggiari, Mario
    Fujiki, Masato
    Diago, Teresa
    Aucejo, Federico N.
    Hashimoto, Koji
    Quintini, Cristiano
    Winans, Charles
    Eghtesad, Bijan
    Miller, Charles M.
    Fung, John J.
    Alkhouri, Naim
    Kelly, Dympna
    [J]. HEPATOLOGY, 2014, 60 : 617A - 617A
  • [6] Non-alcoholic steatohepatitis (NASH)/non-alcoholic fatty liver disease (NAFLD) - A growing epidemic
    South, K
    [J]. GASTROENTEROLOGY NURSING, 2006, 29 (02) : 169 - 169
  • [7] Non-alcoholic Fatty Liver Disease (NAFLD) and non-alcoholic Steatohepatitis (NASH): Pathophysiology and Nutritional Aspects
    Schattenberg, Joern M.
    [J]. ERNAHRUNGS UMSCHAU, 2015, 62 (02): : M92 - M100
  • [8] Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course
    Cortez-Pinto, H
    Camilo, ME
    [J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 (06) : 1089 - 1104
  • [9] Linagliptin is an Effective Therapeutic for Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH)
    Klein, Thomas
    Mark, Michael
    [J]. DIABETES, 2012, 61 : A265 - A266
  • [10] Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
    Miele, Luca
    Forgione, Alessandra
    Gasbarrini, Giovanni
    Grieco, Antonio
    [J]. TRANSLATIONAL RESEARCH, 2007, 149 (03) : 114 - 125
12345